SCHEMBL9257718

SCHEMBL9257718

CC(C)(C)c1ccccc1-c1cccc(Cl)c1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 4/20 0.41
CA2 P00918 1/20 0.40
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
NOTUM Q6P988 1/20 0.37
IDO1 P14902 1/20 0.37
NUDT1 P36639 3/20 0.37
PDK2 Q15119 2/20 0.36
HSD11B1 P28845 1/20 0.36
CYP2A6 P11509 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAOA P21397 1/20 0.35
MAPK1 P28482 1/20 0.35
ADRA1A P35348 1/20 0.35
SCN4A P35499 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9261398 0.85 CYP2A6 (0.44) CA2TSHRALDH1A1TDP1IDO1
SCHEMBL9260774 0.82 CA2 (0.41) P2RX7CA2TSHRALDH1A1TDP1
SCHEMBL19785374 0.81 CA2 (0.48) P2RX7CA2TSHRALDH1A1TDP1
SCHEMBL78891 0.81 CA2 (0.48) CA2TSHRALDH1A1TDP1PDK2
SCHEMBL1194484 0.80 ALDH1A1 (0.55) CA2TSHRALDH1A1TDP1HSD11B1
SCHEMBL9254201 0.78 KDM4E (0.43) P2RX7CA2TSHRALDH1A1TDP1
SCHEMBL545684 0.78 ALDH1A1 (0.52) CA2TSHRALDH1A1TDP1HSD11B1
Phosphine SCHEMBL2238711 0.78 ALDH1A1 (0.52) CA2TSHRALDH1A1TDP1HSD11B1
SCHEMBL440943 0.78 TSHR (0.52) P2RX7TSHRNOTUMIDO1NUDT1
SCHEMBL17031795 0.76 CA2 (0.36) P2RX7CA2TSHRALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND BACE1, STS, APP P2RX7 2615/4885CA2 1210/4885TSHR 2737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.